AKT1 and hepatocellular carcinoma: In both RAS/AKT- and β-catenin/AKT HCC models, untreated HCC had increased HIF1α, activated STAT3, and increased inflammatory signaling of IL6R and IL17A, which were all reduced by miR-22 (Figure 2E).